Home Search
epidiolex - search results
If you're not happy with the results, please do another search
Poll Results: Use Of Street Cannabis Medicinally In The UK
A new poll reveals 2.8% of the British adult population is using "street cannabis" for medicinal purposes - up to 1.4 million people.
A survey...
Lack Of FDA Cannabidiol Regulations Rattles U.S. Consumers
A recent poll indicates 44% of Americans are less likely to use cannabidiol products after learning the FDA is yet to implement consumer protection...
Epidyolex Receives European Commission Approval
GW Pharmaceuticals has announced it has received marketing authorisation for Epidyolex (not a typo) for treating certain conditions in all 28 EU countries as...
Another Warning Shot From FTC On Cannabidiol Claims
Last week the U.S. Federal Trade Commission sent more warning letters to companies over claims it alleges have been made relating to cannabidiol (CBD).
This...
USA FDA Excited About Cannabidiol, But..
A U.S. FDA official has spoken positively about the potential for cannabidiol, but says more research is required.
At the National Industrial Hemp Council 2019...
Support For Medicinal Marijuana In The U.S Remains Strong
No surprises here - a new poll indicates the vast majority of Americans support legalising medical marijuana.
The YouGov poll taken between October 31 and...
U.S. Customs Shifts Stance On Canadian Cannabis Workers
A tricky situation has perhaps become a little less so for Canadian cannabis industry workers wanting to enter the USA.
Last month we mentioned growing...
U.S. DEA Shifts A Cannabidiol Medicine To Schedule V
The thin edge of the wedge? Cannabidiol is (finally) starting to gain more acceptance by the U.S. Federal Government.
Cannabis, and consequently its compounds, have...
2018 To Be A Breakout Year For U.S. Cannabidiol Sales
The U.S. CBD industry grew by nearly 40 percent in 2017 and is set to eclipse $500 million this year according to a recent...
U.S. FDA Approves Cannabis-Based Medicine
The U.S. Food and Drug Administration has approved a UK company's cannabis-based medicine for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet...
Advertisement
